Infectious complications – Communicable Diseases Research

Obesity, Hypovitaminosis D, and COVID-19: the Bermuda Triangle in Public Health

비만, 비타민 D 부족 및 COVID-19: 공중 보건의 버뮤다 삼각지대

Review

Published on 2022-09-012022-09-11
Journal: Current obesity reports [Category] COVID19(2023년), SARS, 유전자 메커니즘,

Immature granulocytes: Innovative biomarker for SARS‑CoV‑2 infection

미성숙 과립구: SARS‑CoV‑2 감염에 대한 혁신적인 바이오마커

Article

Published on 2022-07-012022-09-11
Journal: Molecular medicine reports [Category] COVID19(2023년), MERS, SARS, 바이오마커, 변종, 치료기술,

[키워드] acute pancreatitis acute respiratory syndrome addition age Alpha Alpha variant Analysis antiviral immune response Bacterial bacterial and fungal infections Biomarker Biomarkers Bone marrow Cardiopulmonary cardiopulmonary bypass clinical conditions Comorbidities complications confounders coronavirus coronavirus disease Coronavirus disease 2019 COVID‐19 critical cases Defense disease severity duration of hospitalization evaluate evaluated fungal infections granulocyte Granulocytes greater Host host defense immature immature granulocytes in viral include Increased independent Infection infections infectious complication Infectious complications intubation involved Logistic regression analysis Male sex Mortality multivariate logistic regression neutrophil Neutrophils Numerous outcomes Pancreatitis Patient patients hospitalized Peripheral blood precursor precursors presence of comorbidity present prognostic biomarker reported Research respiratory severe acute respiratory syndrome Coronavirus severe and critical cases severity significantly syndrome systemic inflammatory response systemic inflammatory response syndrome variant Viral viral infections was measured
[DOI] 10.3892/mmr.2022.12733 PMC 바로가기 [Article Type] Article

Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a prospective, multicentre, controlled, randomized, double-blind trial

간경변 환자에서 양성자 펌프 억제제 치료 중단(STOPPIT): 전향적, 다기관, 대조, 무작위, 이중 맹검 시험을 위한 연구 프로토콜

Article

Published on 2022-04-122022-09-11
Journal: Trials [Category] COVID19(2023년), SARS, 임상,

[키워드] 1:1 bleeding bleeding event cirrhosis clinical Clinical outcome clinical outcomes clinical trial complications composite endpoint control group death defined Diagnosis double-blind trial double-blinded Effect Endpoint Esomeprazole EU Clinical Trials EudraCT evaluate excluded gastritis gastrointestinal bleeding Germany Hemorrhagic hepatic Hepatic encephalopathy Hospitalization Hospitalized Hypothesis IMPROVE include increased risk indication infections Infectious complications inhibitor intervention group intestinal liberal liver Liver cirrhosis liver failure manifestation medication microbiota Mortality multicentre observational studies observational study Occurrence outcome Pantoprazole parallel-group Patient peptic ulcer Placebo placebo-controlled PPI primary composite endpoint Prophylactic Proton-pump inhibitors Randomized rationale receive recruitment reflux esophagitis Registered risk secondary Secondary endpoints Side-effects STOP Study protocol therapy Treatment Trial variable Withdrawal
[DOI] 10.1186/s13063-022-06232-w PMC 바로가기 [Article Type] Article

Reduced dispensing of prescribed antibiotics during the Covid-19 pandemic has not increased severe complications from common infections

Covid-19 Pandemic 동안 처방 된 항생제의 분배 감소는 일반적인 감염으로 인한 심각한 합병증을 증가시키지 않았습니다.

Research

Published on 2022-02-082022-09-10
Journal: BMC Public Health [Category] COVID19(2023년), Fulltext, MERS, SARS, 치료기술, 치료제,

[키워드] accelerated Admission Admissions age antibiotic Antibiotics Bacterial infection Bacterial infections Care Complication COVID-19 COVID-19 pandemic decrease drug group Hospital admission Hospital admissions incidence increase in Infection infections Infectious complications mitigate open otitis Outpatient outpatients pandemic pharmacies Pharmacy Pneumonia prescription Prescriptions reached recommendation remained respiratory respiratory infection respiratory infections Respiratory tract infections Result return severe complication severe complications sinusitis skin infections supplementary material Swedish tonsillitis Treatment urinary tract infection urinary tract infections
[DOI] 10.1186/s12889-022-12692-1 PMC 바로가기 [Article Type] Research

Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study

Observational Study

Published on 2022-02-012022-10-05
Journal: Infection [Category] COVID19(2023년), SARS, 임상,

[키워드] 95% CI acquisition Antibiotic therapy Bacteremia Bacterial infection Characteristics characterized Co-infection collected conducted Course COVID-19 Critically ill patient critically ill patients database eight higher risk hospital ICU ICUs identify incidence infected with COVID-19 Infection infection control Infectious complications Italian Kaplan-Meier analysis limit measure Mortality multicenter Occurrence Odds ratio outcome outcomes Patient patients Prevalence prospective observational study recruited Regular risk secondary secondary bacterial infection study period Surveillance Ventilator-associated pneumonia was used
[DOI] 10.1007/s15010-021-01661-2 PMC 바로가기 [Article Type] Observational Study

Impact of rituximab on COVID-19 outcomes

COVID-19 결과에 대한 리툭시맙의 영향

Article

Published on 2021-11-012022-09-12
Journal: Annals of Hematology [Category] MERS, SARS, 진단,

[키워드] administration Admission Analysis Anti-spike antibodies antibody B-cell B-lymphocytes baseline characteristics checked Clinical outcome clinical outcomes conducted COVID-19 COVID-19 antibody COVID-19 diagnosis death diagnosed with COVID-19 died disease severity examined Hospitalization humoral Humoral immunity Hypogammaglobulinemia ICU admission Impact Infectious complications intensive care unit marker median time Mount Sinai Neutralizing neutralizing antibody not affect not significantly different outcome over Patient Protein required Retrospective study rituximab SARS-CoV-2 SARS-COV-2 infection survived System T-cell immunity therapy
[DOI] 10.1007/s00277-021-04662-1 PMC 바로가기 [Article Type] Article

Safety of Antithymocyte Globulin Use in Kidney Graft Recipients During the COVID-19 Pandemic

COVID-19 팬데믹 기간 동안 신장 이식 수혜자의 항흉선세포 글로불린 사용 안전성

Article

Published on 2021-10-262022-09-12
Journal: Annals of transplantation [Category] MERS, 진단,

Effect of Different Corticosteroid Regimens on the Outcome of Severe COVID-19-Related Acute Respiratory Failure. A Retrospective Analysis

Article

Published on 2021-10-212022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome A single center experience from Pune, Western India

COVID-19 관련 사이토카인 방출 증후군 관리를 위한 토실리주맙과 스테로이드의 병용 요법 인도 서부 푸네의 단일 센터 경험

4900

Published on 2021-07-232022-09-12
Journal: Medicine [Category] 진단,

[키워드] Administered Admission Anti-inflammatory approved Bacterial bacterial and fungal infections blood stream Cardiac arrhythmia Clinical improvement co-morbidities co-morbidity combination therapy Complication conducted COVID-19 CRS Cytokine release syndrome Cytokine storm D-dimer death Dexamethasone effective Efficacy and safety Encephalopathy evaluate females fibrosis Fungal infection hospital Hospital acquired hypertension Hypotension ICU IL-6 incidence increased risk India Infectious complications inflammatory lung damage intensive care intensive care unit interleukin-6 interleukin-6 receptor lung damage Lung fibrosis management Mechanical mechanical ventilation morbidities Mortality not need outcome Patient patients patients with COVID-19 Pneumonia primary endpoint Randomized controlled trials receptor antagonist Relative risk required retrospective cohort study risk factor Safe secondary Secondary outcomes Seven severity significantly single center steroid Steroids syndrome TCZ therapy thought Tocilizumab Treatment Ventilation ventilator worsening
[DOI] 10.1097/MD.0000000000026705 PMC 바로가기 [Article Type] 4900

Treatment with a DPP-4 inhibitor at time of hospital admission for COVID-19 is not associated with improved clinical outcomes: data from the COVID-PREDICT cohort study in The Netherlands

Research Article

Published on 2021-06-262022-10-30
Journal: Journal of Diabetes and Metabolic Disorders [Category] COVID-19,